Kynam-Capital-Management-Lp

Filing Details

13F-HR2025-03-31
Report Date
2025-03-31
Filing Date
2025-05-15
Total Holdings
32
Total Value
1190280157
Accession Number
0001085146-25-003252
Form Type
13F-HR
Manager Name
Kynam-Capital-Management-Lp
Data Enrichment
94% identified
30 identified2 unidentified

Holdings

32 positions
Manager:
Search and click to pin securities to the top
Page 1 of 2
Natera, Inc.
Shares:1.2M
Value:$165.1M
Vaxcyte, Inc.
Shares:3.2M
Value:$120.8M
Celldex Therapeutics, Inc.
Shares:6.5M
Value:$118.0M
Syndax Pharmaceuticals Inc
Shares:8.5M
Value:$104.7M
BIOCRYST PHARMACEUTICALS INC
Shares:8.9M
Value:$67.0M
CG Oncology, Inc.
Shares:2.6M
Value:$64.0M
Viridian Therapeutics, Inc.\DE
Shares:4.7M
Value:$63.4M
Vera Therapeutics, Inc.
Shares:2.4M
Value:$57.6M
Cogent Biosciences, Inc.
Shares:9.1M
Value:$54.5M
Immunocore Holdings plc
Shares:1.7M
Value:$50.3M
Beam Therapeutics Inc.
Shares:2.5M
Value:$49.2M
Wave Life Sciences Ltd.
Shares:4.9M
Value:$39.6M
DYNAVAX TECHNOLOGIES CORP
Shares:2.6M
Value:$34.0M
Travere Therapeutics, Inc.
Shares:1.8M
Value:$32.3M
Tyra Biosciences, Inc.
Shares:2.4M
Value:$22.4M
29286M105
Shares:5.0M
Value:$22.4M
SOLENO THERAPEUTICS INC
Shares:302.5K
Value:$21.6M
Legend Biotech Corp
Shares:610.0K
Value:$20.7M
Cullinan Therapeutics, Inc.
Shares:2.3M
Value:$17.7M
Nurix Therapeutics, Inc.
Shares:800.0K
Value:$9.5M